We are live on !
Find out more
Shah Capital Management Portfolio holdings
AUM
$605M
Turnover
18.18%
1-Year Est. Return
43.69%
This Fund
S&P 500
This Quarter Est. Return
+23.32%
1 Year Est. Return
+43.69%
3 Year Est. Return
+286.68%
5 Year Est. Return
+571.6%
10 Year Est. Return
+6,876.48%
AUM
$605M
AUM Growth
+$79.1M
(+15%)
Cap. Flow
-$4.99M
Cap. Flow % of AUM
Cap. Flow %
-0.82%
Top 10 Holdings %
Top 10 Hldgs %
99.94%
Holding
11
New
2
Increased
2
Reduced
7
Closed
–
Avg Time Held
4.7
years
Top 10 Avg Time Held
4.6
years
Top 20 Avg Time Held
4.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$10.4M |
| 2 |
Elicio Therapeutics
ELTX
|
+$3.47M |
| 3 |
Tronox
TROX
|
+$1.89M |
| 4 |
Real REMAX Group Inc. Common Stock
REAX
|
+$431K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novavax
NVAX
|
+$17.9M |
| 2 |
VEON
VEON
|
+$1.09M |
| 3 |
China Yuchai International
CYD
|
+$873K |
| 4 |
Antero Midstream
AM
|
+$774K |
| 5 |
Canadian Solar
CSIQ
|
+$197K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 56.78% |
| 2 | Healthcare | 22.12% |
| 3 | Consumer Discretionary | 6.77% |
| 4 | Miscellaneous | 5.34% |
| 5 | Consumer Staples | 3.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
VEON
VEON
$5.71B
| $344M | 56.78% |
4,649,172
-18,406
| -0.4% | -$1.09M |
2014 Q4
47 quarters
|
|
|
2
Novavax
NVAX
$1.91B
| $132M | 21.74% |
12,173,481
-1,992,096
| -14% | -$17.9M |
2022 Q4
15 quarters
|
|
|
3
China Yuchai International
CYD
$975M
| $41M | 6.77% |
1,320,058
-20,999
| -2% | -$873K |
2013 Q2
53 quarters
|
|
|
4
Vanguard Short-Term Treasury ETF
VGSH
$35.2B
| $32.3M | 5.34% |
561,531
+179,207
| +47% | +$10.4M |
2022 Q2
17 quarters
|
|
5
New Oriental
EDU
$9.35B
| $16.2M | 2.67% |
291,504
-3,362
| -1% | -$182K |
2021 Q3
20 quarters
|
|
|
6
Tronox
TROX
$543M
| $11.5M | 1.9% |
2,915,807
+344,993
| +13% | +$1.89M |
2025 Q3
4 quarters
|
|
|
7
Antero Midstream
AM
$9.8B
| $10.5M | 1.74% |
521,713
-35,117
| -6% | -$774K |
2020 Q1
26 quarters
|
|
|
8
Canadian Solar
CSIQ
$648M
| $10.5M | 1.73% |
909,571
-14,145
| -2% | -$197K |
2024 Q3
8 quarters
|
|
9
Dole
DOLE
$1.26B
| $5.43M | 0.9% |
427,284
-13,542
| -3% | -$185K |
2022 Q3
16 quarters
|
|
|
10
Elicio Therapeutics
ELTX
$41.2M
| $2.28M | 0.38% |
+1,250,000
| New | +$3.47M |
2026 Q3
0 quarters
|
|
|
11
Real REMAX Group Inc. Common Stock
REAX
$338M
| $350K | 0.06% |
+21,396
| New | +$431K |
2026 Q3
0 quarters
|
|
Similar funds
VV
SFCM
EFL
Shah Capital Management's Q3 2026 Portfolio in Review
As of Q3 2026, Shah Capital Management held 11 positions worth $605M, up 15% from $526M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Shah Capital Management's Q3 2026 filing shows 2 new, 2 increased and 7 reduced positions. Its largest new stake was Elicio Therapeutics: 1,250,000 shares worth $2.28M. The largest sale was Novavax, an estimated $17.9M.
By sector, the portfolio is most concentrated in Communication Services at 57% of assets, up from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Shah Capital Management's largest Q3 2026 buy was Elicio Therapeutics: 1,250,000 shares worth $2.28M.
- Shah Capital Management added most to Vanguard Short-Term Treasury ETF in Q3 2026, an estimated $10.4M increase.
- Shah Capital Management's biggest Q3 2026 reduction was Novavax, cutting an estimated $17.9M.
- Shah Capital Management's ten largest holdings make up 100% of its $605M portfolio in Q3 2026.
- Shah Capital Management opened 2 new positions and closed 0 in Q3 2026.
- Shah Capital Management's portfolio value rose 15% quarter-over-quarter to $605M.
Based on Shah Capital Management's 13F filing for Q3 2026, filed 9 Oct 2026.